CGEMCullinan Therapeutics, Inc.
What is the market doing?
No clear lean: nothing decisive, though heavily shorted (+12% of shares).
Rangebound, no clear trend. Price is −8% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 21% since the previous count, down from 16.5% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CGEM is trading
Cullinan Therapeutics, Inc. is +64% over the past year while the S&P 500 is +16%: 48 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −7.6%
vs 200-day average · below trend, but not far
- RSI (14)
- 38
RSI (14) · neutral
- Below its 52-week high
- 38%
Below its 52-week high
Details›
- Last close2026-10-23
- $14.35
- 1 monthS&P 500 −0.94%
- −7.0%
- 1 yearS&P 500 +16%
- +64%
- 5 yearsS&P 500 +86%
- −38%
- vs 50-day average$18.45
- −22%
- 52-week high
- $22.98
- 52-week low
- $7.19
- Annualised volatility
- 71%
| Year | Return |
|---|---|
| 2026 (year to date) | +39% |
| 2025 | −15% |
| 2024 | +20% |
| 2023 | −3.4% |
| 2022 | −32% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | +9.7% |
| Feb | 6 | 4 of 6 | +7.0% |
| Mar | 6 | 1 of 6 | −10% |
| Apr | 6 | 2 of 6 | +4.4% |
| May | 6 | 4 of 6 | +3.9% |
| Jun | 6 | 3 of 6 | −2.8% |
| Jul | 6 | 3 of 6 | +0.50% |
| Aug | 6 | 3 of 6 | +7.5% |
| Sep | 6 | 0 of 6 | −17% |
| Oct | 6 | 3 of 6 | +6.1% |
| Nov | 5 | 1 of 5 | −3.8% |
| Dec | 5 | 1 of 5 | −4.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.